UROVANT SCIENCES overview

NEW YORK, NY / ACCESSWIRE / December 15, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Urovant Sciences Ltd. (NASDAQ:UROV) Merger Announcement: November 18, 2020 Transaction Details: Sumitovant currently owns 72% of the outstanding shares of Urovant common stock, and under the terms of the merger agreement, will acquire the...

NEW YORK, NY / ACCESSWIRE / December 07, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Urovant Sciences Ltd. (NASDAQ:UROV) Merger Announcement: November 18, 2020 Transaction Details: Sumitovant currently owns 72% of the outstanding shares of Urovant common stock, and under the terms of the merger agreement, will acquire the...